National HealthCare's Vicki Dodson sells 4,834 shares

The senior vice president reported 10,726 shares after the sale and three direct option positions with separate exercise prices and expiration dates.

Rhea-AI Filing Summary

NATIONAL HEALTHCARE CORP (NHC) Sr. VP Patient Srvcs Vicki L. Dodson sold 4,834 shares of common stock at $225.00 per share on September 22, 2026, leaving reported direct holdings of 10,726 shares. The filing lists three direct options to purchase common stock: 4,000 shares at a $94.10 exercise price, expiring March 5, 2029; 9,000 shares at $90.62, expiring February 24, 2030; and 14,000 shares at $157.13, expiring February 23, 2031. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 4,834.0007 shares

Net Sell 4 txns

Insider Dodson Vicki L

Role Sr.VP Patient Srvcs

Sold 4,834.0007 shs ($1.09M)

Type	Security	Shares	Price	Value
Sale	Shares of Common Stock held in my name	4,834.0007	$225.00	$1.09M
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Shares of Common Stock held in my name — 10,725.5448 shares (Direct); Option to Purchase Common Stock — 27,000 contracts (Direct)

Key Figures

Common shares sold: 4,834 shares Sale price: $225.00 per share Direct shares after sale: 10,726 shares +3 more

6 metrics

Common shares sold 4,834 shares September 22, 2026

Sale price $225.00 per share September 22, 2026

Direct shares after sale 10,726 shares Reported following the September 22, 2026 sale

Option tranche expiring March 5, 2029 4,000 underlying shares; $94.10 exercise price Direct option position

Option tranche expiring February 24, 2030 9,000 underlying shares; $90.62 exercise price Direct option position

Option tranche expiring February 23, 2031 14,000 underlying shares; $157.13 exercise price Direct option position

Key Terms

Option to Purchase Common Stock, exercise price, Rule 10b5-1 plan

3 terms

Option to Purchase Common Stock technical

"three direct options to purchase common stock"

exercise price financial

"at a $94.10 exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Rule 10b5-1 plan financial

"No Rule 10b5-1 plan is reported"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NHC shares did Vicki L. Dodson sell, and at what price?

Vicki L. Dodson sold 4,834 shares of NHC common stock at $225.00 per share on September 22, 2026. Her reported direct holdings after the sale were 10,726 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 06:55 PM Accepted by SEC EDGAR 09/23/2026 - 06:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dodson Vicki L

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr.VP Patient Srvcs

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Shares of Common Stock held in my name	09/22/2026		S		4,834.0007	D	$225	10,725.5448	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	4,000		4,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	9,000		9,000	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

	/s/ Vicki L Dodson	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)